Neuromuscular

Immune-mediated necrotizing myopathy

ORPHA:206569 ↗

Search all Immune-mediated necrotizing myopathy trialsAlert me when a trial opens

studies recruiting now

as of 7 Sept 2026

studies registered in total

as of 7 Sept 2026

countries with a recruiting site

as of 7 Sept 2026

28 Jan 2026

most recent study posted

among recruiting studies

Recruiting trials

RecruitingPhase 2 / Phase 3NCT06154252

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

Sponsor Cabaletta BioWhere United States, United Kingdom (35 sites)Studying CABA-201 following preconditioning with fludarabine and cyclophosphamideUpdated 2 Sept 2026

See details

RecruitingPhase 2NCT07103746

Ublituximab in Autoantibody Positive Immune Mediated Necrotizing Myopathy

Sponsor National Institute of Allergy and Infectious Diseases (NIAID)Where United States (8 sites)Studying Ublituximab, Placebo for UblituximabUpdated 10 Aug 2026

See details

RecruitingPhase 2NCT06599697

The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy

Sponsor University of Alabama at BirminghamWhere United States (5 sites)Studying Intravenously administered pooled human immunoglobulin (IVIG)Updated 5 Aug 2026

See details

RecruitingPhase 1NCT06371417

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

Sponsor Chugai PharmaceuticalWhere United States, Australia, Austria +17 (77 sites)Studying RAY121Updated 22 Jul 2026

See details

RecruitingNCT07374107

MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)

Sponsor Myositis International Health & Research Collaborative Alliance FoundationWhere United States (1 site)Studying No intervention - qualitative and mixed methods investigationsUpdated 28 Jan 2026

See details

Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.

See all 6 recruiting studies

Where recruiting studies are running

Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.

Australia Austria Bulgaria Canada Croatia Czechia France Germany Hungary Italy Japan Netherlands Norway Poland Portugal Romania Spain Taiwan Turkey (Türkiye)United Kingdom United States

Keep watching

Get an email when a new Immune-mediated necrotizing myopathy study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

NORD ↗GARD ↗Orphanet ORPHA:206569 ↗

About Immune-mediated necrotizing myopathy

RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.

Orphanet expert page ↗GARD (NIH) ↗

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).